Other safety alerts
|
|
Canada: Robikids and Solmux are unauthorized children’s syrups for thinning mucus and may pose serious health risks |
|
Health Canada is warning parents and caregivers about two unauthorized children's syrups for thinning mucus, Robikids and Solmux, seized from Kamshoppe. The affected products are:
- Robikids Carbocisteine Mucolytic 120ml (250mg/5 ml)
- Solmux Carbocisteine Mucolytic Pediatric Syrup 120ml (200mg/5 ml)
Selling unauthorized health products in Canada is illegal. Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks. For example, they could contain high-risk ingredients, such as prescription drugs, additives or contaminants that may or may not be listed on the label. These ingredients could interact with other medications and foods. In addition, these products may not actually contain the active ingredients that consumers would expect them to contain to help maintain and improve their health.
Prescription drugs should only be used under the advice and supervision of a health care professional because they are used to treat specific conditions and may cause serious side effects.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/robikids-and-solmux-are-unauthorized-children-s-syrups-thinning-mucus-and-may-pose
In Hong Kong, Solmux Pediatric Susp 200mg/5ml (HK-34628) is a pharmaceutical product registered by Unam Corporation Ltd. The packaging of Solmux Carbocisteine Mucolytic Pediatric Syrup 120ml (200mg/5ml) above-mentioned in the Health Canada’s announcement is different from the registered packaging of the product in Hong Kong.
Robikids Carbocisteine Mucolytic 120ml (250mg/5 ml) above-mentioned in the Health Canada’s announcement is not a registered pharmaceutical product in Hong Kong.
Ends/Friday, Mar 17, 2023
Issued at HKT 14:30
|
|